Margaret A Tempero

Margaret A Tempero

UNVERIFIED PROFILE

Are you Margaret A Tempero?   Register this Author

Register author
Margaret A Tempero

Margaret A Tempero

Publications by authors named "Margaret A Tempero"

Are you Margaret A Tempero?   Register this Author

55Publications

1756Reads

9Profile Views

CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma.

Am J Clin Oncol 2019 Dec;42(12):898-902

Department of Medicine, Division of Hematology/Oncology, University of California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000620DOI Listing
December 2019

2019 American Pancreatic Association Presidential Address: On Our Golden Jubilee.

Pancreas 2019 Nov/Dec;48(10):1238-1239

From the Division of Hematology and Oncology, Department of Medicine, UCSF Medical Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000001413DOI Listing
November 2019

Alternate Week Gemcitabine and Capecitabine: An Effective Treatment for Patients With Pancreatic Adenocarcinoma.

Pancreas 2019 08;48(7):927-930

Division of Hematology and Oncology, Department of Medicine, UCSF Medical Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000001354DOI Listing
August 2019

NCCN Guidelines Updates: Pancreatic Cancer.

J Natl Compr Canc Netw 2019 May;17(5.5):603-605

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5007DOI Listing
May 2019

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.

Fam Cancer 2019 04;18(2):241-251

Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-018-0106-2DOI Listing
April 2019

Introduction: Pancreatic Adenocarcinoma: The Emperor of All Cancer Maladies.

Cancer J 2017 Nov/Dec;23(6):309

From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000295DOI Listing
March 2019

Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.

AJR Am J Roentgenol 2018 11 31;211(5):1010-1019. Epub 2018 Jul 31.

2 Department of Medicine, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.18.19602DOI Listing
November 2018

Hypermutation In Pancreatic Cancer.

Gastroenterology 2017 01 15;152(1):68-74.e2. Epub 2016 Nov 15.

Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Department of Surgery, Bankstown Hospital, Bankstown, Sydney, New South Wales, Australia; South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales Australia, Liverpool, New South Wales, Australia; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00165085163518
Publisher Site
http://dx.doi.org/10.1053/j.gastro.2016.09.060DOI Listing
January 2017

Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials.

Pancreas 2016 11;45(10):1394-1400

From the *Department of Medicine, Stanford University School of Medicine, Stanford, CA; †Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL; ‡Department of Oncology, Kaiser Permanente Medical Center, Vallejo; §Department of Oncology, Kaiser Permanente Medical Center, Santa Clara; Departments of ∥Medicine, and ¶Biostatistics and Computational Biology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000659DOI Listing
November 2016

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

J Surg Oncol 2016 Oct 21;114(5):587-596. Epub 2016 Jul 21.

Division of Hematology/Oncology, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24375DOI Listing
October 2016

A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.

Pancreas 2016 Mar;45(3):370-5

From the *Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA; †Division of Hematology/Oncology, University of Wisconsin, Madison, WI; ‡Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; and §Department of Radiology and ∥Division of Hematology/Oncology, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908466PMC
March 2016

Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

Cancer Discov 2016 Mar 29;6(3):270-85. Epub 2015 Dec 29.

Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon. Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783268PMC
March 2016

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

Cancer Discov 2015 Oct 24;5(10):1040-8. Epub 2015 Jun 24.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. Department of Medicine, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592417PMC
October 2015

Multidisciplinary management of pancreatic cancer.

J Natl Compr Canc Netw 2015 May;13(5 Suppl):700-2

Presented by Margaret A. Tempero, MD, Director of the University of California, San Francisco, Pancreas Center; Professor of Medicine at the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; and Editor-in-Chief of JNCCN-Journal of the National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0208DOI Listing
May 2015

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

J Clin Oncol 2015 Feb 20;33(6):654-6. Epub 2015 Jan 20.

Gary H. Lyman, Fred Hutchinson Cancer Research Center; Gary H. Lyman and Nicole M. Kuderer, University of Washington, Seattle, WA; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Alok A. Khorana, Cleveland Clinic, Cleveland, OH; Agnes Y. Lee, University of British Columbia, Vancouver, British Columbia; Mark N. Levine, McMaster University, Hamilton, Ontario, Canada; Juan Ignacio Arcelus, Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain; Edward P. Balaban, Cancer Care Partnership, Mount Nittany Health and Penn State Hershey Cancer Institute, State College, PA; Jeffrey M. Clarke, Duke University Medical Center, Durham; Nigel S. Key, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Christopher R. Flowers, Emory University School of Medicine, Atlanta, GA; Charles W. Francis, James P. Wilmot Cancer Center and University of Rochester, Rochester, NY; Leigh E. Gates, Patient Representative, Denver, CO; Ajay K. Kakkar, Thrombosis Research Institute, London, United Kingdom; Howard A. Liebman, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Margaret A. Tempero, University of California San Francisco Pancreas Center, San Francisco, CA; Sandra L. Wong, University of Michigan, Ann Arbor, MI; and Anna Falanga, Hospital Papa Giovanni XXIII, Bergamo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.7351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881372PMC
February 2015

Whole genomes redefine the mutational landscape of pancreatic cancer.

Nature 2015 Feb;518(7540):495-501

1] Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland 4072, Australia [2] Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523082PMC
February 2015

HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.

NMR Biomed 2014 Nov 9;27(11):1361-70. Epub 2014 Sep 9.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nbm.3198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554431PMC
November 2014

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

J Natl Compr Canc Netw 2014 Aug;12(8):1083-93

From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0106DOI Listing
August 2014

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab.

Pancreas 2014 Apr;43(3):343-9

From the *Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA; †Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY; §Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA; ∥Division of Medical Oncology, College of Medicine, The Ohio State University Medical Center, Columbus, OH; ¶Division of Biomedical Statistics and Informatics, Health Sciences Research Department, The Mayo Clinic, Rochester, MN; and #Division of Hematology and Oncology, The Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955845PMC
April 2014

Monoclonal antibodies and other targeted therapies for pancreatic cancer.

Cancer J 2012 Nov-Dec;18(6):653-64

Department of Medicine, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3182758985DOI Listing
August 2013

Therapeutic advances in pancreatic cancer.

Gastroenterology 2013 Jun;144(6):1316-26

University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.01.078DOI Listing
June 2013

Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer.

Clin Cancer Res 2013 Feb 23;19(3):538-40. Epub 2013 Jan 23.

Pancreas Center, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2745DOI Listing
February 2013

A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.

Cancer Chemother Pharmacol 2012 Dec 28;70(6):875-81. Epub 2012 Sep 28.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-1979-7DOI Listing
December 2012

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Authors:
Andrew V Biankin Nicola Waddell Karin S Kassahn Marie-Claude Gingras Lakshmi B Muthuswamy Amber L Johns David K Miller Peter J Wilson Ann-Marie Patch Jianmin Wu David K Chang Mark J Cowley Brooke B Gardiner Sarah Song Ivon Harliwong Senel Idrisoglu Craig Nourse Ehsan Nourbakhsh Suzanne Manning Shivangi Wani Milena Gongora Marina Pajic Christopher J Scarlett Anthony J Gill Andreia V Pinho Ilse Rooman Matthew Anderson Oliver Holmes Conrad Leonard Darrin Taylor Scott Wood Qinying Xu Katia Nones J Lynn Fink Angelika Christ Tim Bruxner Nicole Cloonan Gabriel Kolle Felicity Newell Mark Pinese R Scott Mead Jeremy L Humphris Warren Kaplan Marc D Jones Emily K Colvin Adnan M Nagrial Emily S Humphrey Angela Chou Venessa T Chin Lorraine A Chantrill Amanda Mawson Jaswinder S Samra James G Kench Jessica A Lovell Roger J Daly Neil D Merrett Christopher Toon Krishna Epari Nam Q Nguyen Andrew Barbour Nikolajs Zeps Nipun Kakkar Fengmei Zhao Yuan Qing Wu Min Wang Donna M Muzny William E Fisher F Charles Brunicardi Sally E Hodges Jeffrey G Reid Jennifer Drummond Kyle Chang Yi Han Lora R Lewis Huyen Dinh Christian J Buhay Timothy Beck Lee Timms Michelle Sam Kimberly Begley Andrew Brown Deepa Pai Ami Panchal Nicholas Buchner Richard De Borja Robert E Denroche Christina K Yung Stefano Serra Nicole Onetto Debabrata Mukhopadhyay Ming-Sound Tsao Patricia A Shaw Gloria M Petersen Steven Gallinger Ralph H Hruban Anirban Maitra Christine A Iacobuzio-Donahue Richard D Schulick Christopher L Wolfgang Richard A Morgan Rita T Lawlor Paola Capelli Vincenzo Corbo Maria Scardoni Giampaolo Tortora Margaret A Tempero Karen M Mann Nancy A Jenkins Pedro A Perez-Mancera David J Adams David A Largaespada Lodewyk F A Wessels Alistair G Rust Lincoln D Stein David A Tuveson Neal G Copeland Elizabeth A Musgrove Aldo Scarpa James R Eshleman Thomas J Hudson Robert L Sutherland David A Wheeler John V Pearson John D McPherson Richard A Gibbs Sean M Grimmond

Nature 2012 Nov 24;491(7424):399-405. Epub 2012 Oct 24.

The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature11547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530898PMC
November 2012

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

Cancer Chemother Pharmacol 2010 Nov 4;66(6):1051-7. Epub 2010 Feb 4.

University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 4th Floor, Box 1705, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00280-010-1257
Web Search
http://link.springer.com/10.1007/s00280-010-1257-5
Publisher Site
http://dx.doi.org/10.1007/s00280-010-1257-5DOI Listing
November 2010

International network of cancer genome projects.

Authors:
Thomas J Hudson Warwick Anderson Axel Artez Anna D Barker Cindy Bell Rosa R Bernabé M K Bhan Fabien Calvo Iiro Eerola Daniela S Gerhard Alan Guttmacher Mark Guyer Fiona M Hemsley Jennifer L Jennings David Kerr Peter Klatt Patrik Kolar Jun Kusada David P Lane Frank Laplace Lu Youyong Gerd Nettekoven Brad Ozenberger Jane Peterson T S Rao Jacques Remacle Alan J Schafer Tatsuhiro Shibata Michael R Stratton Joseph G Vockley Koichi Watanabe Huanming Yang Matthew M F Yuen Bartha M Knoppers Martin Bobrow Anne Cambon-Thomsen Lynn G Dressler Stephanie O M Dyke Yann Joly Kazuto Kato Karen L Kennedy Pilar Nicolás Michael J Parker Emmanuelle Rial-Sebbag Carlos M Romeo-Casabona Kenna M Shaw Susan Wallace Georgia L Wiesner Nikolajs Zeps Peter Lichter Andrew V Biankin Christian Chabannon Lynda Chin Bruno Clément Enrique de Alava Françoise Degos Martin L Ferguson Peter Geary D Neil Hayes Thomas J Hudson Amber L Johns Arek Kasprzyk Hidewaki Nakagawa Robert Penny Miguel A Piris Rajiv Sarin Aldo Scarpa Tatsuhiro Shibata Marc van de Vijver P Andrew Futreal Hiroyuki Aburatani Mónica Bayés David D L Botwell Peter J Campbell Xavier Estivill Daniela S Gerhard Sean M Grimmond Ivo Gut Martin Hirst Carlos López-Otín Partha Majumder Marco Marra John D McPherson Hidewaki Nakagawa Zemin Ning Xose S Puente Yijun Ruan Tatsuhiro Shibata Michael R Stratton Hendrik G Stunnenberg Harold Swerdlow Victor E Velculescu Richard K Wilson Hong H Xue Liu Yang Paul T Spellman Gary D Bader Paul C Boutros Peter J Campbell Paul Flicek Gad Getz Roderic Guigó Guangwu Guo David Haussler Simon Heath Tim J Hubbard Tao Jiang Steven M Jones Qibin Li Nuria López-Bigas Ruibang Luo Lakshmi Muthuswamy B F Francis Ouellette John V Pearson Xose S Puente Victor Quesada Benjamin J Raphael Chris Sander Tatsuhiro Shibata Terence P Speed Lincoln D Stein Joshua M Stuart Jon W Teague Yasushi Totoki Tatsuhiko Tsunoda Alfonso Valencia David A Wheeler Honglong Wu Shancen Zhao Guangyu Zhou Lincoln D Stein Roderic Guigó Tim J Hubbard Yann Joly Steven M Jones Arek Kasprzyk Mark Lathrop Nuria López-Bigas B F Francis Ouellette Paul T Spellman Jon W Teague Gilles Thomas Alfonso Valencia Teruhiko Yoshida Karen L Kennedy Myles Axton Stephanie O M Dyke P Andrew Futreal Daniela S Gerhard Chris Gunter Mark Guyer Thomas J Hudson John D McPherson Linda J Miller Brad Ozenberger Kenna M Shaw Arek Kasprzyk Lincoln D Stein Junjun Zhang Syed A Haider Jianxin Wang Christina K Yung Anthony Cros Anthony Cross Yong Liang Saravanamuttu Gnaneshan Jonathan Guberman Jack Hsu Martin Bobrow Don R C Chalmers Karl W Hasel Yann Joly Terry S H Kaan Karen L Kennedy Bartha M Knoppers William W Lowrance Tohru Masui Pilar Nicolás Emmanuelle Rial-Sebbag Laura Lyman Rodriguez Catherine Vergely Teruhiko Yoshida Sean M Grimmond Andrew V Biankin David D L Bowtell Nicole Cloonan Anna deFazio James R Eshleman Dariush Etemadmoghadam Brooke B Gardiner Brooke A Gardiner James G Kench Aldo Scarpa Robert L Sutherland Margaret A Tempero Nicola J Waddell Peter J Wilson John D McPherson Steve Gallinger Ming-Sound Tsao Patricia A Shaw Gloria M Petersen Debabrata Mukhopadhyay Lynda Chin Ronald A DePinho Sarah Thayer Lakshmi Muthuswamy Kamran Shazand Timothy Beck Michelle Sam Lee Timms Vanessa Ballin Youyong Lu Jiafu Ji Xiuqing Zhang Feng Chen Xueda Hu Guangyu Zhou Qi Yang Geng Tian Lianhai Zhang Xiaofang Xing Xianghong Li Zhenggang Zhu Yingyan Yu Jun Yu Huanming Yang Mark Lathrop Jörg Tost Paul Brennan Ivana Holcatova David Zaridze Alvis Brazma Lars Egevard Egor Prokhortchouk Rosamonde Elizabeth Banks Mathias Uhlén Anne Cambon-Thomsen Juris Viksna Fredrik Ponten Konstantin Skryabin Michael R Stratton P Andrew Futreal Ewan Birney Ake Borg Anne-Lise Børresen-Dale Carlos Caldas John A Foekens Sancha Martin Jorge S Reis-Filho Andrea L Richardson Christos Sotiriou Hendrik G Stunnenberg Giles Thoms Marc van de Vijver Laura van't Veer Fabien Calvo Daniel Birnbaum Hélène Blanche Pascal Boucher Sandrine Boyault Christian Chabannon Ivo Gut Jocelyne D Masson-Jacquemier Mark Lathrop Iris Pauporté Xavier Pivot Anne Vincent-Salomon Eric Tabone Charles Theillet Gilles Thomas Jörg Tost Isabelle Treilleux Fabien Calvo Paulette Bioulac-Sage Bruno Clément Thomas Decaens Françoise Degos Dominique Franco Ivo Gut Marta Gut Simon Heath Mark Lathrop Didier Samuel Gilles Thomas Jessica Zucman-Rossi Peter Lichter Roland Eils Benedikt Brors Jan O Korbel Andrey Korshunov Pablo Landgraf Hans Lehrach Stefan Pfister Bernhard Radlwimmer Guido Reifenberger Michael D Taylor Christof von Kalle Partha P Majumder Rajiv Sarin T S Rao M K Bhan Aldo Scarpa Paolo Pederzoli Rita A Lawlor Massimo Delledonne Alberto Bardelli Andrew V Biankin Sean M Grimmond Thomas Gress David Klimstra Giuseppe Zamboni Tatsuhiro Shibata Yusuke Nakamura Hidewaki Nakagawa Jun Kusada Tatsuhiko Tsunoda Satoru Miyano Hiroyuki Aburatani Kazuto Kato Akihiro Fujimoto Teruhiko Yoshida Elias Campo Carlos López-Otín Xavier Estivill Roderic Guigó Silvia de Sanjosé Miguel A Piris Emili Montserrat Marcos González-Díaz Xose S Puente Pedro Jares Alfonso Valencia Heinz Himmelbauer Heinz Himmelbaue Victor Quesada Silvia Bea Michael R Stratton P Andrew Futreal Peter J Campbell Anne Vincent-Salomon Andrea L Richardson Jorge S Reis-Filho Marc van de Vijver Gilles Thomas Jocelyne D Masson-Jacquemier Samuel Aparicio Ake Borg Anne-Lise Børresen-Dale Carlos Caldas John A Foekens Hendrik G Stunnenberg Laura van't Veer Douglas F Easton Paul T Spellman Sancha Martin Anna D Barker Lynda Chin Francis S Collins Carolyn C Compton Martin L Ferguson Daniela S Gerhard Gad Getz Chris Gunter Alan Guttmacher Mark Guyer D Neil Hayes Eric S Lander Brad Ozenberger Robert Penny Jane Peterson Chris Sander Kenna M Shaw Terence P Speed Paul T Spellman Joseph G Vockley David A Wheeler Richard K Wilson Thomas J Hudson Lynda Chin Bartha M Knoppers Eric S Lander Peter Lichter Lincoln D Stein Michael R Stratton Warwick Anderson Anna D Barker Cindy Bell Martin Bobrow Wylie Burke Francis S Collins Carolyn C Compton Ronald A DePinho Douglas F Easton P Andrew Futreal Daniela S Gerhard Anthony R Green Mark Guyer Stanley R Hamilton Tim J Hubbard Olli P Kallioniemi Karen L Kennedy Timothy J Ley Edison T Liu Youyong Lu Partha Majumder Marco Marra Brad Ozenberger Jane Peterson Alan J Schafer Paul T Spellman Hendrik G Stunnenberg Brandon J Wainwright Richard K Wilson Huanming Yang

Nature 2010 Apr;464(7291):993-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature08987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902243PMC
April 2010

Personalized medicine for pancreatic cancer: a step in the right direction.

Gastroenterology 2009 Jan 28;136(1):43-5. Epub 2008 Nov 28.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.11.027DOI Listing
January 2009

A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?

Invest New Drugs 2008 Oct 1;26(5):463-71. Epub 2008 Apr 1.

University of California at San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, 4th floor, Box 1705, San Francisco, CA, 94115, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-008-9127-2
Publisher Site
http://dx.doi.org/10.1007/s10637-008-9127-2DOI Listing
October 2008

A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.

Int J Radiat Oncol Biol Phys 2007 Jul 23;68(3):809-16. Epub 2007 Mar 23.

Division of Hematology/Oncology, University of California at San Francisco, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160700118
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2007.01.005DOI Listing
July 2007

Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.

J Clin Oncol 2006 Jan 12;24(3):379-85. Epub 2005 Dec 12.

University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.01.8267
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.01.8267DOI Listing
January 2006

Pancreatic cancer in mice and man: the Penn Workshop 2004.

Cancer Res 2006 Jan;66(1):14-7

Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-3914DOI Listing
January 2006

Systemic therapy for pancreatic cancer.

Semin Radiat Oncol 2005 Oct;15(4):245-53

San Francisco Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2005.06.001DOI Listing
October 2005

Treatment of metastatic pancreatic cancer.

J Natl Compr Canc Netw 2005 Sep;3(5):627-36

Division of Medical Oncology, University of California at San Francisco Comprehensive Cancer Center, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2005.0036DOI Listing
September 2005

Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.

Int J Gastrointest Cancer 2003 ;34(2-3):107-16

Radiation Oncology, Wake Forest University Comprehensive Cancer Center, Winston-Salem, NC 277516, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/ijgc:34:2-3:107DOI Listing
January 2005

Clinical oncology 2004: the president's report.

J Clin Oncol 2004 Nov;22(22):4437-41

University of California San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.10.520DOI Listing
November 2004

Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a.

J Nucl Med 2002 Jul;43(7):957-67

Department of Radiation Oncology, University of Nebraska Medical Center, Omaha 68198-1050, USA.

View Article

Download full-text PDF

Source
July 2002

Current and future strategies for combined-modality therapy in pancreatic cancer.

Curr Oncol Rep 2002 May;4(3):202-12

Comprehensive Cancer Center, University of California at San Francisco, 1600 Divisadero Street, 4th floor, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-002-0017-zDOI Listing
May 2002